Loading data
PCSANasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | — | — | 5.8 m USD | 11.49 m USD | 6.88 m USD |
| Operating profit | -13.99 m USD | -12.05 m USD | -11.46 m USD | -27.53 m USD | -12.13 m USD |
| Profit before tax | -13.56 m USD | -11.85 m USD | -11.12 m USD | -27.42 m USD | -11.96 m USD |
| Income tax expense | — | — | — | — | -530.61 k USD |
| Net income (reported basis) | -13.56 m USD | -11.85 m USD | -11.12 m USD | -27.47 m USD | -11.43 m USD |
| Net income attributable to common shareholders | -13.56 m USD | -11.85 m USD | -11.12 m USD | -27.42 m USD | — |
| Basic earnings per share | -10.36 USD/share | -96.78 USD/share | -8.48 USD/share | -34.05 USD/share | -0.75 USD/share |
| Diluted earnings per share | -10.36 USD/share | -96.78 USD/share | -8.48 USD/share | -34.05 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.